Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager ...
MP0632 nominated as first logic-gated Switch-DARPin T cell engager candidate for the treatment of MSLN/EpCAM expressing solid tumors, with preclinical data indicating favorable therapeutic window MP0712, Radio-DARPin candidate in on-going US Phase 1…